183 related articles for article (PubMed ID: 21779950)
1. B and T lymphocyte attenuator regulates the development of antigen-induced experimental conjunctivitis.
Ishida W; Fukuda K; Kajisako M; Sumi T; Matsuda H; Yagita H; Fukushima A
Graefes Arch Clin Exp Ophthalmol; 2012 Feb; 250(2):289-95. PubMed ID: 21779950
[TBL] [Abstract][Full Text] [Related]
2. Roles of OX40 in the development of murine experimental allergic conjunctivitis: exacerbation and attenuation by stimulation and blocking of OX40.
Fukushima A; Yamaguchi T; Ishida W; Fukata K; Yagita H; Ueno H
Invest Ophthalmol Vis Sci; 2006 Feb; 47(2):657-63. PubMed ID: 16431965
[TBL] [Abstract][Full Text] [Related]
3. Notch ligand Delta-like4 inhibits the development of murine experimental allergic conjunctivitis.
Fukushima A; Sumi T; Ishida W; Ojima A; Kajisako M; Koyanagi A; Koyama N; Yagita H
Immunol Lett; 2008 Dec; 121(2):140-7. PubMed ID: 19027794
[TBL] [Abstract][Full Text] [Related]
4. Participation of CD11b and F4/80 molecules in the conjunctival eosinophilia of experimental allergic conjunctivitis.
Fukushima A; Ishida W; Ojima A; Kajisako M; Sumi T; Yamada J; Tsuru E; Miyazaki J; Tominaga A; Yagita H
Int Arch Allergy Immunol; 2010; 151(2):129-36. PubMed ID: 19752566
[TBL] [Abstract][Full Text] [Related]
5. Treatment with FTY720 during the induction or effector phase suppresses the development of experimental allergic conjunctivitis in mice.
Sumi T; Fukushima A; Nishino K; Fukuda K; Kumagai N; Nishida T; Ueno H
Cell Biol Int; 2009 Apr; 33(4):534-41. PubMed ID: 19230848
[TBL] [Abstract][Full Text] [Related]
6. Interleukin 10 and transforming growth factor beta contribute to the development of experimentally induced allergic conjunctivitis in mice during the effector phase.
Fukushima A; Sumi T; Fukuda K; Kumagai N; Nishida T; Yagita H; Ueno H
Br J Ophthalmol; 2006 Dec; 90(12):1535-41. PubMed ID: 16914468
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibodies to B and T lymphocyte attenuator (BTLA) have no effect on in vitro B cell proliferation and act to inhibit in vitro T cell proliferation when presented in a cis, but not trans, format relative to the activating stimulus.
Zhang M; Howard K; Winters A; Steavenson S; Anderson S; Smelt S; Doellgast G; Sheelo C; Stevens J; Kim H; Hamburger A; Sein A; Caughey DJ; Lee F; Hsu H; Siu G; Byrne FR
Clin Exp Immunol; 2011 Jan; 163(1):77-87. PubMed ID: 21078085
[TBL] [Abstract][Full Text] [Related]
8. Involvement of programmed death-ligand 2 (PD-L2) in the development of experimental allergic conjunctivitis in mice.
Fukushima A; Yamaguchi T; Azuma M; Yagita H; Ueno H
Br J Ophthalmol; 2006 Aug; 90(8):1040-5. PubMed ID: 16613922
[TBL] [Abstract][Full Text] [Related]
9. CD27 and CD70 do not play a critical role in the development of experimental allergic conjunctivitis in mice.
Sumi T; Ishida W; Ojima A; Kajisako M; Sakanishi T; Yagita H; Fukushima A
Immunol Lett; 2008 Aug; 119(1-2):91-6. PubMed ID: 18579220
[TBL] [Abstract][Full Text] [Related]
10. Regulatory T cells participate in 4-1BB-mediated suppression of experimental allergic conjunctivitis.
Sumi T; Ishida W; Mittler RS; Yagita H; Taguchi O; Fukushima A
Int Arch Allergy Immunol; 2009; 148(4):305-10. PubMed ID: 19001790
[TBL] [Abstract][Full Text] [Related]
11. Endogenous interleukin-10 produced by antigen-irrelevant cells promotes the development of experimental murine allergic conjunctivitis.
Fukushima A; Sumi T; Fukuda K; Kumagai N; Nishida T; Ueno H
Int Arch Allergy Immunol; 2007; 144(1):79-84. PubMed ID: 17505142
[TBL] [Abstract][Full Text] [Related]
12. Endogenous IL-17 does not play a significant role in the development of experimental murine allergic conjunctivitis.
Fukushima A; Sumi T; Ishida W; Yamada J; Iwakura Y; Ueno H
Int Arch Allergy Immunol; 2008; 147(3):206-12. PubMed ID: 18594150
[TBL] [Abstract][Full Text] [Related]
13. Fyn regulates eosinophil infiltration into the conjunctiva by downregulating the Th2 response.
Fukushima A; Yamaguchi T; Ozaki A; Taniguchi T; Udaka K; Ueno H
Graefes Arch Clin Exp Ophthalmol; 2005 Oct; 243(10):1043-9. PubMed ID: 15838661
[TBL] [Abstract][Full Text] [Related]
14. Roles of CD4+CD25+ T cells in the development of experimental murine allergic conjunctivitis.
Fukushima A; Yamaguchi T; Sumi T; Fukuda K; Kumagai N; Nishida T; Takeuchi M; Taguchi O; Ueno H
Graefes Arch Clin Exp Ophthalmol; 2007 May; 245(5):705-14. PubMed ID: 17024440
[TBL] [Abstract][Full Text] [Related]
15. T follicular helper expansion and humoral-mediated rejection are independent of the HVEM/BTLA pathway.
Rodriguez-Barbosa JI; Fernandez-Renedo C; Moral AMB; Bühler L; Del Rio ML
Cell Mol Immunol; 2017 Jun; 14(6):497-510. PubMed ID: 26924526
[TBL] [Abstract][Full Text] [Related]
16. Role of VLA-4 in the development of allergic conjunctivitis in mice.
Fukushima A; Yamaguchi T; Ishida W; Fukata K; Ueno H
Mol Vis; 2006 Apr; 12():310-7. PubMed ID: 16617298
[TBL] [Abstract][Full Text] [Related]
17. T cell intrinsic heterodimeric complexes between HVEM and BTLA determine receptivity to the surrounding microenvironment.
Cheung TC; Oborne LM; Steinberg MW; Macauley MG; Fukuyama S; Sanjo H; D'Souza C; Norris PS; Pfeffer K; Murphy KM; Kronenberg M; Spear PG; Ware CF
J Immunol; 2009 Dec; 183(11):7286-96. PubMed ID: 19915044
[TBL] [Abstract][Full Text] [Related]
18. CD8+ T cells play disparate roles in the induction and the effector phases of murine experimental allergic conjunctivitis.
Fukushima A; Yamaguchi T; Fukuda K; Sumi T; Kumagai N; Nishida T; Imai S; Ueno H
Microbiol Immunol; 2006; 50(9):719-28. PubMed ID: 16985294
[TBL] [Abstract][Full Text] [Related]
19. Roles of galectin-9 in the development of experimental allergic conjunctivitis in mice.
Fukushima A; Sumi T; Fukuda K; Kumagai N; Nishida T; Okumura K; Akiba H; Yagita H; Ueno H
Int Arch Allergy Immunol; 2008; 146(1):36-43. PubMed ID: 18087160
[TBL] [Abstract][Full Text] [Related]
20. A herpesvirus entry mediator mutein with selective agonist action for the inhibitory receptor B and T lymphocyte attenuator.
Šedý JR; Balmert MO; Ware BC; Smith W; Nemčovičova I; Norris PS; Miller BR; Aivazian D; Ware CF
J Biol Chem; 2017 Dec; 292(51):21060-21070. PubMed ID: 29061848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
